Background and activities
Scientific, academic and artistic work
A selection of recent journal publications, artistic productions, books, including book and report excerpts. See all publications in the database
- (2018) The effect of including bone in DIXON-based attenuation correction for 18F-fluciclovine PET/MRI of prostate cancer. Journal of Nuclear Medicine. vol. 59 (12).
- (2018) Simultaneous 18F-fluciclovine Positron Emission Tomography and Magnetic Resonance Spectroscopic Imaging of Prostate Cancer. Frontiers in Oncology. vol. 8.
- (2018) 18F-Fluciclovine PET/MRI for preoperative lymph node staging in high-risk prostate cancer patients. European Radiology.
- (2017) Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy. British Journal of Cancer. vol. 117 (11).
- (2017) Combined 18F-Fluciclovine PET/MRI shows potential for detection and characterization of high-risk prostate cancer. Journal of Nuclear Medicine. vol. 59 (5).
- (2017) Geometric distortion correction in prostate diffusion-weighted MRI and its effect on quantitative apparent diffusion coefficient analysis. Magnetic Resonance in Medicine. vol. 79 (5).
- (2017) High-Quality 3-Dimensional 1H Magnetic Resonance Spectroscopic Imaging of the Prostate Without Endorectal Receive Coil Using A Semi-LASER Sequence. Investigative Radiology. vol. 52 (10).
- (2016) A PET/MRI study towards finding the optimal [18F]Fluciclovine PET protocol for detection and characterisation of primary prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging.
- (2016) Presence of TMPRSS2-ERG is associated with alterations of the metabolic profile in human prostate cancer. OncoTarget.
- (2016) T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results. European Radiology.
- (2016) A novel non-canonical Wnt signature for prostate cancer aggressiveness. OncoTarget. vol. 8 (6).
- (2016) Tissue microstructure is linked to MRI parameters and metabolite levels in prostate cancer. Frontiers in Oncology. vol. 6:146.
- (2013) Spermine and Citrate as Metabolic Biomarkers for Assessing Prostate Cancer Aggressiveness. PLoS ONE. vol. 8 (4).
- (2013) Spatially matched in vivo and ex vivo MR metabolic profiles of prostate cancer - investigation of a correlation with Gleason score. NMR in Biomedicine. vol. 26 (5).
- (2013) Quality control of prostate H-1 MRSI data. NMR in Biomedicine. vol. 26 (2).
- (2012) Citrat og Spermin som markører for aggressiv prostatakreft. Vitenskapelige forhandlinger / De norske kirurgiske foreninger.
- (2012) Peripheral Zone Prostate Cancer Localization by Multiparametric Magnetic Resonance at 3 T: Unbiased Cancer Identification by Matching to Histopathology. Investigative Radiology. vol. 47 (11).
- (2010) Discrimination of Patients with Microsatellite Instability Colon Cancer using H-1 HR MAS MR Spectroscopy and Chemometric Analysis. Journal of Proteome Research. vol. 9 (7).
- (2012) MR Imaging and Spectroscopy in Prostate and Colon Cancer Diagnostics. Norges teknisk-naturvitenskapelige universitet. 2012. ISBN 978-82-471-3809-0.